Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1949 1
1953 1
1959 1
1963 1
1964 3
1976 1
1977 1
1979 1
1980 1
1982 1
1983 1
1984 1
1985 2
1987 1
1988 1
1991 1
1995 1
1997 1
2003 1
2006 1
2007 1
2008 1
2009 1
2010 2
2012 2
2013 3
2014 3
2015 3
2017 4
2018 4
2019 2
2020 4
2021 2
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Proximity search should include two or more words. Proximity operator ignored :~0
Page 1
Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment.
Pasquel FJ, Umpierrez GE. Pasquel FJ, et al. Diabetes Care. 2014 Nov;37(11):3124-31. doi: 10.2337/dc14-0984. Diabetes Care. 2014. PMID: 25342831 Free PMC article. Review.
The hyperosmolar hyperglycemic state (HHS) is the most serious acute hyperglycemic emergency in patients with type 2 diabetes. von Frerichs and Dreschfeld described the first cases of HHS in the 1880s in patients with an "unusual diabetic coma" characterized by severe hyperglycem …
The hyperosmolar hyperglycemic state (HHS) is the most serious acute hyperglycemic emergency in patients with type 2 diabetes. von Frerichs …
Approach and management of dysnatremias in cirrhosis.
Bernardi M, Zaccherini G. Bernardi M, et al. Hepatol Int. 2018 Nov;12(6):487-499. doi: 10.1007/s12072-018-9894-6. Epub 2018 Sep 10. Hepatol Int. 2018. PMID: 30203382 Review.
Hypernatremia usually follows hypotonic fluid losses due to osmotic diuresis (glycosuria) or lactulose-induced diarrhea. The main clinical manifestations of dysnatremias are due to their effects on the central nervous system: astroglial cell hyperhydration follows hyponatr …
Hypernatremia usually follows hypotonic fluid losses due to osmotic diuresis (glycosuria) or lactulose-induced diarrhea. The main cli …
Recommendations for self-monitoring in pediatric diabetes: a consensus statement by the ISPED.
Scaramuzza A, Cherubini V, Tumini S, Bonfanti R, Buono P, Cardella F, d'Annunzio G, Frongia AP, Lombardo F, Monciotti AC, Rabbone I, Schiaffini R, Toni S, Zucchini S, Frontino G, Iafusco D; Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetology. Scaramuzza A, et al. Acta Diabetol. 2014 Apr;51(2):173-84. doi: 10.1007/s00592-013-0521-7. Epub 2013 Oct 27. Acta Diabetol. 2014. PMID: 24162715 Review.
After an extensive review of the literature, we took these issues into account: self-monitoring blood glucose, continuous glucose monitoring, glycemic variability, glycosuria, ketonuria, ketonemia, glycated hemoglobin, fructosamine and glycated albumin, logbook, data downl …
After an extensive review of the literature, we took these issues into account: self-monitoring blood glucose, continuous glucose monitoring …
Methods for the screening and diagnosis of gestational diabetes mellitus between 24 and 28 weeks of pregnancy.
Virally M, Laloi-Michelin M. Virally M, et al. Diabetes Metab. 2010 Dec;36(6 Pt 2):549-65. doi: 10.1016/j.diabet.2010.11.008. Diabetes Metab. 2010. PMID: 21163420 Review.
A discussion of alternative methods revealed that measuring Fasting Glycaemia (FG) between 24 and 28 weeks of pregnancy was unsuitable, and that measuring HbA1c, fructosamine, glycosuria, or random and postprandial plasma glucose was not advisable. ...
A discussion of alternative methods revealed that measuring Fasting Glycaemia (FG) between 24 and 28 weeks of pregnancy was unsuitable, and …
Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: evidence to date.
Cinti F, Moffa S, Impronta F, Cefalo CM, Sun VA, Sorice GP, Mezza T, Giaccari A. Cinti F, et al. Drug Des Devel Ther. 2017 Oct 3;11:2905-2919. doi: 10.2147/DDDT.S114932. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 29042751 Free PMC article. Review.
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are the latest therapeutic strategy in the treatment of type 2 diabetes mellitus (T2DM). Using an insulin-independent mechanism (glycosuria), they reduce glucose toxicity and improve insulin sensitivity and beta-cell …
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are the latest therapeutic strategy in the treatment of type 2 diabetes mellitus (T …
SGLT2 inhibition: a novel prospective strategy in treatment of diabetes mellitus.
Deshmukh AB, Patel MC, Mishra B. Deshmukh AB, et al. Ren Fail. 2013;35(4):566-72. doi: 10.3109/0886022X.2013.766560. Epub 2013 Feb 25. Ren Fail. 2013. PMID: 23438184 Review.
The role of the kidney in glucose homeostasis and the potential of the kidney as a therapeutic target in type 2 diabetes is little appreciated. Hyperglycemia is an important pathogenic component in the development of microvascular and macrovascular complications in type 2 …
The role of the kidney in glucose homeostasis and the potential of the kidney as a therapeutic target in type 2 diabetes is little ap …
Recent Advances in the Development of Type 2 Sodium-Glucose Cotransporter Inhibitors for the Treatment of Type 2 Diabetes Mellitus.
Estrada AK, Delgado-Maldonado T, Lara-Ramírez EE, Martínez-Vázquez AV, Ortiz-Pérez E, Paz-González AD, Bandyopadhyay D, Rivera G. Estrada AK, et al. Mini Rev Med Chem. 2022;22(4):586-599. doi: 10.2174/1389557521666210805112416. Mini Rev Med Chem. 2022. PMID: 34353256 Review.
The anti-hyperglycemic mechanism of action of these drugs involves glycosuria. In addition, SGLT2 inhibitors cause beneficial effects such as weight loss, a decrease in blood pressure, and others. ...
The anti-hyperglycemic mechanism of action of these drugs involves glycosuria. In addition, SGLT2 inhibitors cause beneficial effects …
Challenges in management of diabetic ketoacidosis in hemodialysis patients, case presentation and review of literature.
Seddik AA, Bashier A, Alhadari AK, AlAlawi F, Alnour HH, Bin Hussain AA, Frankel A, Railey MJ. Seddik AA, et al. Diabetes Metab Syndr. 2019 Jul-Aug;13(4):2481-2487. doi: 10.1016/j.dsx.2019.06.022. Epub 2019 Jun 28. Diabetes Metab Syndr. 2019. PMID: 31405665 Review.
DKA is uncommon in hemodialysis patients because of the absence of glycosuria and osmotic diuresis which accounts for most of the fluid and electrolyte losses seen in DKA, anuric patients may be somewhat protected from dehydration and shock, although still subject to hyper …
DKA is uncommon in hemodialysis patients because of the absence of glycosuria and osmotic diuresis which accounts for most of the flu …
Use of SGLT-2 inhibitors in the treatment of type 2 diabetes mellitus.
Santos LL, Lima FJC, Sousa-Rodrigues CF, Barbosa FT. Santos LL, et al. Rev Assoc Med Bras (1992). 2017 Jul;63(7):636-641. doi: 10.1590/1806-9282.63.07.636. Rev Assoc Med Bras (1992). 2017. PMID: 28977090 Free article. Review.
Although there are several classes of oral antidiabetic agents, most of the patients are outside the therapeutic goal range. OBJECTIVE: To review the use of SGLT-2 inhibitors in the treatment of type 2 diabetes mellitus, focusing on their favorable and unfavorable effects, …
Although there are several classes of oral antidiabetic agents, most of the patients are outside the therapeutic goal range. OBJECTIV …
Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review.
Jensterle M, Rizzo M, Haluzík M, Janež A. Jensterle M, et al. Adv Ther. 2022 Jun;39(6):2452-2467. doi: 10.1007/s12325-022-02153-x. Epub 2022 May 3. Adv Ther. 2022. PMID: 35503498 Free PMC article. Review.
Some hypothetical explanations for the weaker anti-obesity response for both GLP-1 RAs in people with diabetes include the background medications that promote weight gain, the fear of hypoglycaemia inherently related to the treatment of diabetes, a decrease in glycosuria a …
Some hypothetical explanations for the weaker anti-obesity response for both GLP-1 RAs in people with diabetes include the background medica …
56 results